Kauffman R E, Sawyer L A, Scheinbaum M L
Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI.
Am J Dis Child. 1992 May;146(5):622-5. doi: 10.1001/archpedi.1992.02160170102024.
To compare the antipyretic efficacy of ibuprofen, placebo, and acetaminophen.
Double-dummy, double-blind, randomized, placebo-controlled trial.
Emergency department and inpatient units of a large, metropolitan, university-based, children's hospital in Michigan.
37 otherwise healthy children aged 2 to 12 years with acute, intercurrent, febrile illness.
Each child was randomly assigned to receive a single dose of acetaminophen (10 mg/kg), ibuprofen (7.5 or 10 mg/kg), or placebo.
MEASUREMENTS/MAIN RESULTS: Oral temperature was measured before dosing, 30 minutes after dosing, and hourly thereafter for 8 hours after the dose. Patients were monitored for adverse effects during the study and 24 hours after administration of the assigned drug. All three active treatments produced significant antipyresis compared with placebo. Ibuprofen provided greater temperature decrement and longer duration of antipyresis than acetaminophen when the two drugs were administered in approximately equal doses. No adverse effects were observed in any treatment group.
Ibuprofen is a potent antipyretic agent and is a safe alternative for the selected febrile child who may benefit from antipyretic medication but who either cannot take or does not achieve satisfactory antipyresis with acetaminophen.
比较布洛芬、安慰剂和对乙酰氨基酚的退热效果。
双盲双模拟、随机、安慰剂对照试验。
密歇根州一家大型都市大学附属医院的急诊科和住院部。
37名2至12岁、患有急性、并发、发热性疾病的健康儿童。
每个孩子随机分配接受单剂量对乙酰氨基酚(10毫克/千克)、布洛芬(7.5或10毫克/千克)或安慰剂。
测量指标/主要结果:给药前、给药后30分钟以及给药后每小时测量一次口腔温度,持续8小时。在研究期间以及给药后24小时对患者进行不良反应监测。与安慰剂相比,所有三种活性治疗均产生显著的退热作用。当两种药物以大致相等的剂量给药时,布洛芬比乙酰氨基酚能使体温下降更多,退热持续时间更长。任何治疗组均未观察到不良反应。
布洛芬是一种有效的退热剂,对于可能从退热药物中获益但不能服用对乙酰氨基酚或服用对乙酰氨基酚后退热效果不佳的特定发热儿童来说,是一种安全的替代药物。